MoneyWorks4Me

Net sales declined -11.91%  to  Rs. 140.39 million from Rs. 159.37 millions.The Net Loss for the quarter ended December 2022 is Rs. -2.26 millions as compared to Net Profit of Rs. 0.56 millions of corresponding quarter ended December 2021A decline of 12.48 millions was observed in the OP in the quarter ended December 2022 from 14.27 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 140.39 159.37 -11.91 505.19 527.12 -4.16 694.30 560.15 23.95
Other Income 0.90 0.97 -7.22 2.01 1.90 5.79 5.92 5.85 1.20
PBIDT 12.48 14.27 -12.54 72.25 72.60 -0.48 90.07 88.17 2.15
Interest 5.65 4.29 31.70 18.56 14.82 25.24 20.66 22.06 -6.35
PBDT 6.83 9.98 -31.56 53.69 57.78 -7.08 69.41 66.11 4.99
Depreciation 9.85 9.23 6.72 29.21 25.83 13.09 35.48 35.11 1.05
PBT -3.02 0.75 -502.67 24.48 31.95 -23.38 33.93 31.00 9.45
TAX -0.76 0.19 -500.00 6.11 7.99 -23.53 7.50 7.75 -3.23
Deferred Tax 0.52 0.37 40.54 1.40 2.31 -39.39 3.05 2.46 23.98
PAT -2.26 0.56 -503.57 18.37 23.96 -23.33 26.43 23.25 13.68
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 8.89 8.95 -0.72 14.30 13.77 3.84 12.97 15.74 -17.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..